These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25412860)

  • 21. The role of microRNAs in the regulation of insulin signaling pathway with respect to metabolic and mitogenic cascades: A review.
    Ebrahimi R; Bahiraee A; Niazpour F; Emamgholipour S; Meshkani R
    J Cell Biochem; 2019 Dec; 120(12):19290-19309. PubMed ID: 31364207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?
    Prattichizzo F; Giuliani A; De Nigris V; Pujadas G; Ceka A; La Sala L; Genovese S; Testa R; Procopio AD; Olivieri F; Ceriello A
    Diabetes Obes Metab; 2016 Sep; 18(9):855-67. PubMed ID: 27161301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression. Results from micro-array profiling in a cohort of 60 patients.
    Stratz C; Nührenberg T; Fiebich BL; Amann M; Kumar A; Binder H; Hoffmann I; Valina C; Hochholzer W; Trenk D; Neumann FJ
    Thromb Haemost; 2014 May; 111(5):902-11. PubMed ID: 24352417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-cell differentiation status in type 2 diabetes.
    Jeffery N; Harries LW
    Diabetes Obes Metab; 2016 Dec; 18(12):1167-1175. PubMed ID: 27550203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmentation of histone deacetylase 3 (
    Sathishkumar C; Prabu P; Balakumar M; Lenin R; Prabhu D; Anjana RM; Mohan V; Balasubramanyam M
    Clin Epigenetics; 2016; 8():125. PubMed ID: 27904654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA Methylation: An Epigenetic Insight into Type 2 Diabetes Mellitus.
    Alam F; Islam MA; Gan SH; Mohamed M; Sasongko TH
    Curr Pharm Des; 2016; 22(28):4398-419. PubMed ID: 27229720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. microRNAs in Pancreatic β-Cell Physiology.
    Özcan S
    Adv Exp Med Biol; 2015; 887():101-17. PubMed ID: 26662988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic modification of miR-10a regulates renal damage by targeting CREB1 in type 2 diabetes mellitus.
    Shan Q; Zheng G; Zhu A; Cao L; Lu J; Wu D; Zhang Z; Fan S; Sun C; Hu B; Zheng Y
    Toxicol Appl Pharmacol; 2016 Sep; 306():134-43. PubMed ID: 27292126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of competitive endogenous RNA network reveals regulatory role of long non-coding RNAs in type 2 diabetes mellitus.
    Lin Z; Li X; Zhan X; Sun L; Gao J; Cao Y; Qiu H
    J Cell Mol Med; 2017 Dec; 21(12):3204-3213. PubMed ID: 28643459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs in the pathogenesis of type 2 diabetes: new research progress and future direction.
    Miao C; Zhang G; Xie Z; Chang J
    Can J Physiol Pharmacol; 2018 Feb; 96(2):103-112. PubMed ID: 28898588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes.
    Sathishkumar C; Prabu P; Mohan V; Balasubramanyam M
    Hum Genomics; 2018 Aug; 12(1):41. PubMed ID: 30139387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation in the pathogenesis of type 2 diabetes.
    Kaimala S; Ansari SA; Emerald BS
    Vitam Horm; 2023; 122():147-169. PubMed ID: 36863792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus.
    Hashimoto N; Tanaka T
    J Hum Genet; 2017 Feb; 62(2):141-150. PubMed ID: 27928162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does epigenetic dysregulation of pancreatic islets contribute to impaired insulin secretion and type 2 diabetes?
    Dayeh T; Ling C
    Biochem Cell Biol; 2015 Oct; 93(5):511-21. PubMed ID: 26369706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interplay between noncoding RNAs and insulin in diabetes.
    Tian Y; Xu J; Du X; Fu X
    Cancer Lett; 2018 Apr; 419():53-63. PubMed ID: 29371021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micro-RNA Binding Site Polymorphisms in the WFS1 Gene Are Risk Factors of Diabetes Mellitus.
    Elek Z; Németh N; Nagy G; Németh H; Somogyi A; Hosszufalusi N; Sasvári-Székely M; Rónai Z
    PLoS One; 2015; 10(10):e0139519. PubMed ID: 26426397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment.
    Yaribeygi H; Katsiki N; Behnam B; Iranpanah H; Sahebkar A
    Metabolism; 2018 Oct; 87():48-55. PubMed ID: 30253864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating Exosomal miR-20b-5p Is Elevated in Type 2 Diabetes and Could Impair Insulin Action in Human Skeletal Muscle.
    Katayama M; Wiklander OPB; Fritz T; Caidahl K; El-Andaloussi S; Zierath JR; Krook A
    Diabetes; 2019 Mar; 68(3):515-526. PubMed ID: 30552111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes.
    Nigi L; Grieco GE; Ventriglia G; Brusco N; Mancarella F; Formichi C; Dotta F; Sebastiani G
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.